Podcasts about Jabbour

Fumaça branca no Vaticano: Leão XIV, originalmente o cardeal Robert Prevost, dos Estados Unidos, é o novo chefe da Igreja Católica, e vai suceder o papa Francisco – originalmente, o argentino Jorge Mário Bergoglio, que morreu em 21 de abril. Veja mais no "Fechamento" desta semana: Sergio Lirio e Fabiola Mendonça recebem o geógrafo, professor e escritor Elias Jabbour, conhecido por seus estudos sobre o desenvolvimento econômico da China, para uma conversa sobre a visita de Lula ao país asiático. Jabbour também foi Diretor de Pesquisas do Novo Banco de Desenvolvimento (NDB), o chamado "Banco dos Brics", posto assumido a convite da presidenta do banco, Dilma Rousseff. Antes de visitar Pequim, Lula passa por Moscou, Rússia, onde será recebido por Vladimir Putin e acompanhará a parada do Dia da Vitória, em comemoração ao fim da Segunda Guerra.Também nesta edição: as tensões entre Índia e Paquistão. As novas ofensivas de Israel para tomar o controle total da Faixa de Gaza. Em Brasília, a manobra dos bolsonaristas para tentar emplacar, mais uma vez, uma Lei de Anistia. E, no STF, a primeira turma torna réus sete membros do "núcleo da desinformação" da trama golpista.

Use code YDSAMPLE for a free snack pack from Skratch Labs!Support us on Patreon!Is organic food actually healthier—or just more expensive? This week on Your Diet Sucks, Zoë and Kylee break down the real science behind organic food, including what “organic” really means for produce, meat, and packaged snacks. We cover nutrition claims, pesticide exposure, antioxidant levels, and whether organic food impacts inflammation, gut health, or performance. We also dive into the environmental trade-offs of organic farming, the high cost of certification, and why that $19 strawberry feels morally superior. Plus: the truth behind the Dirty Dozen list, who really benefits from organic labels, and how to make food choices that work for your body and your budget.Big thanks to Microcosm Coaching for supporting the pod! We coach humans, not just athletes. Reach out for a free consultation and meet someone who's genuinely on your team.ReferencesBaranski, M., Średnicka-Tober, D., Volakakis, N., Seal, C., Sanderson, R., Stewart, G. B., ... & Leifert, C. (2014). Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: A systematic literature review and meta-analyses. British Journal of Nutrition, 112(5), 794–811. https://doi.org/10.1017/S0007114514001366Średnicka-Tober, D., Baranski, M., Seal, C., Sanderson, R., Benbrook, C., Steinshamn, H., ... & Leifert, C. (2016). Composition differences between organic and conventional meat: a systematic literature review and meta-analysis. British Journal of Nutrition, 115(6), 994–1011. https://doi.org/10.1017/S0007114515005073Seufert, V., Ramankutty, N., & Foley, J. A. (2012). Comparing the yields of organic and conventional agriculture. Nature, 485(7397), 229–232. https://doi.org/10.1038/nature11069Smith-Spangler, C., Brandeau, M. L., Hunter, G. E., Bavinger, J. C., Pearson, M., Eschbach, P. J., ... & Bravata, D. M. (2012). Are organic foods safer or healthier than conventional alternatives? A systematic review. Annals of Internal Medicine, 157(5), 348–366. https://doi.org/10.7326/0003-4819-157-5-201209040-00007Tuomisto, H. L., Hodge, I. D., Riordan, P., & Macdonald, D. W. (2012). Does organic farming reduce environmental impacts? – A meta-analysis of European research. Journal of Environmental Management, 112, 309–320. https://doi.org/10.1016/j.jenvman.2012.08.018Clark, M., & Tilman, D. (2017). Comparative analysis of environmental impacts of agricultural production systems, agricultural input efficiency, and food choice. Environmental Research Letters, 12(6), 064016. https://doi.org/10.1088/1748-9326/aa6cd5Kniss, A. R., Savage, S. D., & Jabbour, R. (2016). Commercial crop yields reveal strengths and weaknesses for organic agriculture in the United States. PLoS ONE, 11(8), e0161673. https://doi.org/10.1371/journal.pone.0161673

Elias Jabbour e Gabriel Lazzari debateram o significado da disputa entre EUA e China sob perspectivas diferentes.

Deixe um recadinho para nós via: entreprosasedivagacoes@gmail.comNosso Instagram: https://bit.ly/2VR9MZi|Nosso Twitter: https://bit.ly/2KOtrTaNosso Tik Tok : https://encurtador.com.br/ukYwfBIBLIOGRAFIAJABBOUR, Elias. China: O Socialismo do século XXI.JABBOUR, Elias. China: socialismo e desenvolvimento sete décadas depois.JABBOUR, Elias. China Hoje: Projeto Nacional, Desenvolvimento e Socialismo de Mercado.https://www.youtube.com/watch?v=Y_SKL_d30iQ&pp=ygUTam9hbyBjYXJ2YWxobyBjaGluYQ%3D%3Dhttps://www.youtube.com/watch?v=pfpUTf_C8bAhttps://www.youtube.com/watch?v=6uJOi9-QMpk

Ele é mestre e doutor em geografia humana pela USP e enveredou para o campo da economia. Hoje, além de presidente do Instituto Municipal de Urbanismo Pereira Passos, da Prefeitura do Rio, é professor associado da Faculdade de Ciências Econômicas da Universidade do Estado do Rio de Janeiro (FCE-UERJ) e dos programas de pós-graduação da instituição em Ciências Econômicas e Relações Institucionais. Foi também consultor sênior do Banco dos Brics nos anos de 2023 e 2024. Marxista sem medo de ser feliz nem solitário, tornou-se um estudioso da China e desafia alguns consensos sobre aquele país: ele nega, por exemplo, que os chineses tenham uma vocação imperialista. Para Jabbour, o Brasil cometeu um “erro chocante” ao se negar a integrar a “Nova Rota da Seda”. Fica fácil saber por que as direitas não gostam dele. Nesta entrevista, ele explica por que nem sempre se entende também com as esquerdas. Não perca o pensamento de Jabbour em estado puro.

In today's episode, supported by Takeda, we had the pleasure of speaking with Ibrahim T. Aldoss, MD, and Elias Jabbour, MD, about the use of ponatinib (Iclusig) monotherapy after combination chemotherapy in patients with newly diagnosed Philadelphia chromosome–positive (Ph)–positive acute lymphoblastic leukemia (ALL). Dr Aldoss is an associate professor in the Division of Leukemia in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. Jabbour is a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Drs Aldoss and Jabbour discussed findings from a post hoc subgroup analysis of the phase 3 PhALLCON trial (NCT03589326) that support the use of ponatinib monotherapy following combination treatment with a TKI plus chemotherapy in patients with newly diagnosed Ph-positive ALL, safety considerations when using ponatinib in this patient population, and how findings from this subgroup analysis may affect transplantation rates in this disease.

Rosine Dallos Jabbour, country manager de Samsonite by Diario La república

In today's episode, supported by Takeda, we had the pleasure of speaking with Mark B. Geyer, MD, and Elias Jabbour, MD, about updates in the management of Philadelphia chromosome (Ph)–positive acute lymphoblastic leukemia (ALL). Dr Geyer is the Adolescent and Young Adult Program leader and the Adult Lymphoblastic Leukemia Program leader in the Leukemia Service, as well as the chair of Quality Assessment in the Cellular Therapy Service at Memorial Sloan Kettering Cancer Center in New York, New York. Dr Jabbour is a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Drs Geyer and Jabbour discussed the use of ponatinib (Iclusig) in patients with Ph-positive ALL as evidenced by key findings from research such as the pivotal phase 3 PhALLCON trial (NCT03589326). They also highlighted the potential efficacy of this agent in combination with blinatumomab (Blincyto) and shared insights on how the safety profile of this agent affects its clinical use.

In today's episode, supported by Ascentage Pharma, we had the pleasure of speaking with Elias Jabbour, MD, a professor in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. In our exclusive interview, Dr Jabbour discussed the 1.5-year follow-up data from a phase 1b trial (NCT04260022) investigating olverembatinib (HQP1351) in patients with heavily pretreated chronic-phase chronic myeloid leukemia (CML), enrollment considerations for the registrational phase 3 POLARIS-2 trial (NCT06423911) that is further evaluating the agent in this population, and potential future research directions in CML.

Salve camaradas, Hoje no Manhã Brasil, Mauro Lopes entrevistou Elias Jabbour, na conversa ele destacou o afastamento do Brasil do BRICS e de bandeiras estratégicas da política externa brasileira. Elias Jabbour, presidente do IPP (Instituto Pereira Passos), da Prefeitura do Rio. Ele acaba de voltar ao Brasil depois de dois anos na China, na Diretoria de Pesquisas do NBD (Novo Banco de Desenvolvimento), dos Brics. O banco é comandado pela ex-presidenta Dilma Rousseff (PT). Jabbour é um estudioso da experiência chinesa há décadas, autor, entre outros livros de “China, o socialismo do século 21” (Boitempo, 2021);

If you are feeling stuck or you want to grow in your business or career, you need to listen to this interview. The truly divine, Pamela Jabbour, founder of Total Image Group and Capsule Collection Wardrobe shares her secret sauce on how she built and grew a multi million dollar business despite often succumbing to 'imposter syndrome".How she used the power of networking, community and connection and the one incredible (yet simple) thing she did to grow her business into the multi million dollar enterprise it is today.You can find Pamela here:IG: https://www.instagram.com/pamjabbour/Linkedin: https://www.linkedin.com/in/pamela-jabbour-875a2325/Website: www.totalimagegroup.comwww.capsulecollectionwardrobe.com.auSupport the show: https://www.libbyallaway.com.au/See omnystudio.com/listener for privacy information.

Anem tirant d'estètica. Crítica teatral de l'obra «Tirant lo Blanc». Text de Màrius Serra (a partir del clàssic de Joanot Martorell). Música original: Judit Neddermann. Intèrprets: Quim Àvila, Laura Aubert, Moha Amazian, Neus Ballbé, Agnès Jabbour, Clara Mingueza, Judit Neddermann i Ireneu Tranis. Escenografia: Judit Colomer. Vestuari: Nídia Tusal. Il·luminació: Toni Ubach. Espai sonor: Roger Giménez i Neus Ballbé. Moviment escènic i ajudantia de direcció: Carla Tovias. Caracterització: Núria Llunell. Coach de dramatúrgia i assessorament en diversitat: Denise Duncan. Direcció de producció: Maite Pijuan. Producció executiva: Raquel Doñoro. Direcció tècnica: Moi Cuenca. Regidoria: Lluc Armengol. Sastreria: Nerea Casas. Caps tècnics del teatre: Sergi Lobaco i Raúl Martínez. Construcció de l'escenografia: Pascualín Estructures, Taller d'Escenografia Castells. Construcció del titella: Glòria Arrufat i Marc Costa. Confecció del vestuari: Consol Díaz i Nídia Tusal. Màrqueting i comunicació: Teatre Romea. Fotografia: David Ruano. Col·laboradors: Jorge de la Gaza, Montibello, Rowenta i Mikakus Barcelona. Amb el suport de la Generalitat de Catalunya - ICEC Institut Català de les Empreses Culturals. Disrribució: Carme Tierz. Direcció: Joan Arqué. Festival Grec 2024. Teatre Romea, Barcelona, 4 juliol 2024. Veu: Andreu Sotorra. Música: Propiñán de Melyor. Interpetació: Capella de Ministrers i Carles Magraner. Composició: Anònim s. XV. Àlbum: Els viatges de Tirant lo Blanc, 2010.

EN: In this episode of Seeing Clearly, Mohamed Gemae and Anas Abu-Dieh (two Eye Curriculum Ambassadors) talk to Dr. Samir Jabbour, cornea specialist at the University of Montréal and McGill University. This is the fourth episode of our french mini-series (“Vision Claire”).  Dr. Jabbour is a cornea specialist at the Centre Hospitalier de l'Université de Montréal (CHUM). He is also an associate professor at the University of Montreal and McGill University. Dr. Jabbour completed his medical studies at McGill University and his residency at the University of Montreal. He completed a clinical subspecialty in cornea, anterior segment, and refractive surgery at the Wilmer Eye Institute at Johns Hopkins. He has a second clinical fellowship in cornea from Moorfields Eye Hospital in London, United Kingdom. Dr. Jabbour is an ophthalmologist and clinician-scientist specializing in the treatment of diseases of the anterior segment of the eye, including corneal grafts and ocular surface reconstruction. His research areas encompass advanced techniques in keratoplasty, cataract surgery, and refractive surgery. Additionally, Dr. Jabbour has a particular interest in public health and is currently pursuing a master's degree in this field at Harvard University. In this episode, we discuss: Dr. Jabbour's unique journey in ophthalmology What a "Day in the Life" of Dr. Jabbour looks like His experience in the United States of America and in the United Kingdom His passion for research Advice for medical students/residents People who have inspired him in life! Check out our website: www.eyecurriculum.com Follow us on Instagram: www.instagram.com/EyeCurriculum Follow us on Twitter: www.twitter.com/EyeCurriculum Dans cet épisode de Seeing Clearly, Mohamed Gemae et Anas Abu-Dieh (ambassadeurs de Eye Curriculum) discutent avec Dr Samir Jabbour, un spécialiste en cornée et la chirurgie réfractive à l'Université de Montréal et à l'Université McGill. Ceci est le quatrième épisode de la mini-série Francophone, “Vision Claire”. Dr Jabbour est un spécialiste en glaucome au Centre Hospitalier Universitaire de l'Université de Montréal (CHUM). Il est aussi professeur associé à l'Université de Montréal et à l'Université McGill. Dr Jabbour a complété ses études en médecine à McGill et sa résidence à l'Université de Montréal. Il a complété une sous-spécialisation clinique en cornée, du segment antérieur et chirurgie réfractive au Wilmer Eye Institute à John Hopkins. Il a un deuxième fellowship clinique en cornée de l'hôpital Moorfields Eye Hospital, à Londres au Royaume-Uni. Dr Jabbour est ophtalmologiste et clinicien-chercheur spécialisé dans le traitement des maladies du segment antérieur de l'œil, notamment les greffes de cornée et la reconstruction de la surface oculaire. Ses domaines de recherche englobent les techniques avancées en kératoplastie, la chirurgie de la cataracte et la chirurgie réfractive. Par ailleurs, Dr Jabbour possède une expertise en santé publique et poursuit actuellement une maîtrise dans ce domaine à l'Université Harvard. Dans cet épisode, nous abordons : Le parcours de Dr Jabbour en ophtalmologie À quoi ressemble une "Journée dans la vie" de Dr Jabbour Ses expériences aux États-Unis d'Amérique et au Royaume-Uni Sa passion pour la recherche  Des conseils pour les étudiants en médecine/résidents Des personnes qui l'ont inspiré dans sa vie!

Dr Jabbour expands on the multiple milestones achieved through ponatinib's FDA approval for patients with Ph-positive ALL; the agent's potency and unique mechanism of action; and key efficacy and safety data from the PhALLCON trial supporting this regulatory decision.

Elias Jabbour, MD, an Executive Editor of Blood Cancers Today and a Professor of Leukemia at the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss the function of measurable residual disease in treating acute lymphocytic leukemia (ALL) and other progress that has been made in treating patients with Philadelphia chromosome-positive and Philadelphia chromosome-negative ALL.  Dr. Jabbour also provides a brief historical perspective on tyrosine kinase inhibitors (TKIs), explaining how the therapies have improved survival outcomes in Ph+ ALL with or without transplantation. 

✅ retrouve moi sur Instagram, youtube et TikTok

Salma Jabbour, MD, Professor and Vice Chair of Radiation Oncology at Rutgers Cancer Institute, provides an invaluable perspective rooted in her extensive experience and passion for radiation oncology. Dr. Jabbour delves into the transformative changes witnessed in radiation oncology over the past two decades, contrasting its trajectory with precision oncology. She shares compelling insights into the PROSPECT trial's innovative approach of omitting radiation therapy entirely for rectal cancer patients, emphasizing the "impressive" results unveiled in the study. Then, the New York Times articles characterizing radiation as "brutal" for patients in this context is considered, and Dr. Jabbour navigates the complexities, challenges, and potential paradigm shifts these findings might signal for the field. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

SERGE A. JABBOUR, MD, FACP, FACE is a Professor of Medicine and the Director of the Division of Endocrinology, Diabetes, and Metabolic Diseases at Jefferson. He is also the Director of the Jefferson Diabetes Center. Dr Jabbour completed his training in Endocrinology, Diabetes, and Metabolic Diseases at Thomas Jefferson University in Philadelphia.Dr Jabbour has been recognized with many honors and he is holder of many teaching awards. Dr Jabbour was named Top Doc in Philadelphia area every year since 2011 by Philadelphia Magazine and one of the best endocrinologists in the nation by Castle Connolly every year since 2012. Dr Jabbour is a member of numerous professional organizations, including The Endocrine Society, American Diabetes Association and American Association of Clinical Endocrinologists.Dr Jabbour has published many articles and chapters on diabetes, metabolic syndrome, various endocrine topics; he serves on the Editorial Board of many journals and he just finished in September 2021 his 5-year tenure as the Chair of the Endocrine Board Review Committee for The Endocrine Society.Dr Jabbour's main research interest is in the field of diabetes. He is involved in many clinical research trials related to new diabetes drugs. He also gives many lectures all over the world on different endocrine topics, mainly diabetes, either in the setting of grand rounds, symposia or other CME presentations. I am truly honored to have such an inspiring and world-class endocrinologist with me today. Welcome Dr. Jabbour, let's see how many people we can convince to do endocrinology.Jefferson Endocrinology:https://www.jeffersonhealth.org/clinical-specialties/endocrinology-diabetes-metabolic-diseases?gclid=CjwKCAjwiOCgBhAgEiwAjv5whBW4FTPRCa_lVxnQI577rjIie4qMEkxca7tNsBwTxndwYCamtYfiMBoCknsQAvD_BwEJefferson Diabetes Center:https://www.jeffersonhealth.org/clinical-specialties/diabetes-center___0:00 - Intro1:49 - Statistics About Endocrinology3:10 - What Is Endocrinology?5:22 - Journey Into Medicine and Endocrinology13:07 - Keeping the Team Happy15:42 - An Average Day/Week of an Endocrinologist19:40 - Advice for People Looking Into Leveling up Ranks22:50 - If I Give You $100 Million, What Would You Do?25:25 - Best Thing About Being an Endocrinologist27:35 - Making a Rare Diagnosis32:16 - Passion for Studying Diabetes34:21 - Things We Should Know About Type 2 & 1 Diabetes53:06 - What Do You Think About Ozempic and Glp-1?59:44 - Dietary Tips1:06:21 - Hemoglobin a1c Levels1:20:10 - SGLT2 Inhibitors1:16:48 - Future of Endocrinology1:19:34 - Changes Over the Years1:20:17 - Myths About Diabetes1:24:29 - High Number of Diabetic Patients in the U.S.1:30:39 - Advice to People Looking Into Endocrinology1:32:36 - Maximizing Competitiveness Going Into Endocrinology1:39:00 - What Makes the Best-Med Students/Residents/Fellows?1:42:28 - Advice to People Entering a Career in Medicine1:45:17 - What Advice Would You Give Your 18-Year-Old Self?1:48:20 - Adapting to the U.S.1:49:43 - Closing Message1:51:57 - Outro__ResourcesWho Moved My Cheese? by Dr Spencer Johnson: https://amzn.eu/d/dZHrYY8 ___View the Show Notes Page for This Episode for transcript and more information: zhighley.com/podcast___Connect With ZachMain YouTube: @ZachHighley Newsletter: https://zhighley.com/newsletter/Instagram: https://www.instagram.com/zachhighley/?hl=enWebsite: https://zhighley.comTwitter: https://twitter.com/zachhighleyLinkedln: https://www.linkedin.com/in/zach-highley-gergel-44763766/Business Inquiries: zachhighley@nebula.tv___Listen for FreeSpotify: https://open.spotify.com/show/23TvJdEBAJuW5WY1QHEc6A?si=cf65ae0abbaf46a4Apple Podcast: https://podcasts.apple.com/us/podcast/the-zach-highley-show/id1666374777___Welcome to the Zach Highley Show, where we discuss personal growth and medicine to figure out how to improve our lives. My name is Zach a Resident Physician in Boston. Throughout these episodes I'll interview top performers from around the world in business, life, and medicine in hopes of extracting the resources and techniques they use to get to the top.The best way to help the show is share episodes on any platform. If you think a friend or family member will like a certain episode, send it to them!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr Jabbour discusses the activity and the utilization of olverembatinib in chronic myeloid leukemia and expanded upon the role that TKIs can play in the management of malignancies beyond chronic myeloid leukemia and acute lymphoblastic leukemia.

Thanks for listening to Episode #51 of the EDventUres in Tech Podcast. In this podcast episode, we interview Dr. Michael Jabbour, the Chief Innovation Officer at Microsoft, and discuss the transformative world of Artificial Intelligence (AI), from its fundamentals to its uncharted propensity to 'hallucinate. ⁠⁠⁠EDventUres in Tech Website⁠⁠⁠ Once again, thank you for all your support in listening on all platforms and leaving us a review. If you have any questions, comments, or suggestions, please reach out. Tech Hard again. Work smart. Live an EDventUre. --- Support this podcast: https://podcasters.spotify.com/pod/show/andrew-nikola/support

Join Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, and Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute, as they delve into the depths of radiation therapy in cancer care. Together they'll unravel the intricacies of this vital treatment option, covering its mechanisms, innovations, and the pivotal role it plays in the journey towards effective oncological treatment for patients. For more information, please visit: www.CarisLifeSciences.com

Elias Jabbour, MD, of the University of MD Anderson Cancer Center stops by The HemOnc Pulse for a live show at the Eleventh Annual Meeting of the Society of Hematologic Oncology in Houston, Texas. In this episode, Dr. Jabbour, who is also an Associate Editor of Blood Cancers Today, the home of The HemOnc Pulse, discusses the most burning questions in acute lymphoblastic leukemia (ALL).

President of the Narset fan club, George Jabbour, joins Stanislav to go over some tips to prep for the upcoming Modern RCQ season, a brand new sideboard guide tool, and why playing control is such a pain in the @$$. Stan and George are gearing up for some Modern RCQs this weekend, so they swap notes on how they prepare for competitive tournaments in any format. Plus, George talks about his brand new sideboard tool, flexslot.gg, which he developed himself and is free for anyone to use. Finally, we dive into control strategies, which are near and dear to George's heart, to go over why they're so tough to play, how they stack up against today's Modern metagame, and why some people should probably avoid them. The Break Down: How to prepare for a Modern tournament. The Dive Down: Never playing control again. Become a citizen of The Dive Down Nation!: http://www.patreon.com/thedivedown Show the world that you're a proud citizen of The Dive Down Nation with some merch from the store: https://www.thedivedown.com/store Upgrade your gameplay and your gameday with Heavy Play accessories. Use code THEDIVEDOWN2023 for 10% off your first order at https://www.heavyplay.com Check out our sponsor Barrister and Mann! https://www.barristerandmann.com/ Use coupon code THEDIVEDOWN23 for 15% off your first order of some incredible fragrances, soaps, beard oils, and more. Get 10% off your first 2 months of ManaTraders! https://www.manatraders.com/?medium=thedivedown and use coupon code THEDIVEDOWN23 And now receive 8% off your order of paper cards from Nerd Rage Gaming with code DIVE8 at https://www.nerdragegaming.com/ Timestamps: 1:12 - Stan gets Heavy 3:33 - Housekeeping 5:55 - George in the Grinder's Studio 17:41 - Tournament prep practices 48:19 - Sideboarding and flexspot.gg 1:00:25 - Special Shane smell appearance 1:04:40 - Talking about Control 1:14:07 - How to think about playing Control 1:21:48 - Evaluating Control finishers 1:27:47 - Controls matchups 1:36:38 - Promoting George 1:38:33 - Wrapping up Links from this week's episode: https://linktr.ee/jabjabber https://shuddermtg.substack.com/p/how-bad-practice-can-make-you-worse-085 Our opening music is Nowhere - You Never Knew, and our closing music is Space Blood - Goro? Is That Your Christian Name? email us: thedivedown@gmail.com (mailto:thedivedown@gmail.com) twitter: https://twitter.com/thedivedown

I had a great, very informative chat with Carl Jabbour, Head of Investors and COO of £1bn+ property and SME  lender Fiduciam, for the podcast.  We talked about:  Why family offices and institutional investors are so keen to lend, and the non-cyclical growth of non-bank lending How macroeconomic shifts like high inflation, high interest rates and low economic growth/confidence define what works for Family Offices and institutional investors Why lenders are swallowing profit margin in the face of higher base rates, and what distinguishes lenders who will survive, thrive or fold in the 2020s Guest website: https://fiduciam.co.uk/ Guest LinkedIn: https://www.linkedin.com/in/carl-jabbour/ Host LinkedIn: https://www.linkedin.com/in/annaclareharper/ Host website: https://www.greenresi.com/

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute. Together they discuss a plenary presentation that was given at ASCO 2023 on rectal cancer titled, the PROSPECT (Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and TME) trial. The PROSPECT trial attempts to challenge the current treatment paradigm by individualizing treatment through the use of radiotherapy selectively rather than reflexively. This is a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for the treatment of locally advanced rectal cancer (LARC). For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

St. Thomas criminologist Michael Boudreau addresses the RCMP's shortcomings in rural policing in the wake of vigilantism on Deer Island, NB, and the Mass Casualty Commission's recommendations. And on the phone-in, our gardening expert Nikki Jabbour answers all your horticultural questions!

In this showcase series of the best scuba diving app on the market today, we discuss how divers can setup a profile, and (finally) get tipped! This interview takes place on the beaches of Oahu, Hawaii, with Guest Alexis Jabbour. She's the mastermind behind the Buddy App, now over 2.5 years in the making! With the Summer 2023 launch happening as we speak, Buddy is making waves throughout the industry as a disruptive platform that's quickly changing the landscape for divers, freedivers, and snorkelers. With the tipping feature built right into the Buddy Profile, we no longer have to remember our cash, find an ATM, or worse… forget and never see the divemasters or boat crew again.  Not only can dives be validated and buddies be added to dive that show up in the dive log, it's an easy way to find and tip those who deserve it, even after-the-fact! The Buddy Dive Log app has the best of all the agencies like PADI, SSI, NAUI, and goes well beyond the capabilities of Manufacturer apps like Garmin, Suunto, Apple Watch and many others. It combines all the features into one, without those barriers that divide the already-small industry even smaller. Connecting buddies of ALL agencies is the skeleton key of all future growth in this watery world. Making sure hardworking scuba instructors, boat hands, and divemasters get paid is equally important. This app, yet again, fixes a lingering rankle within the dive industry. Further, Alexis talks about the Charter and Dive shops features that allow those QR codes to be posted for those who pool their tips. It's clean, works smoothly, easy to use, and is the most comprehensive diver app YET. It got me excited enough to continue interviewing and discussing this incredible new tool, and making it part of our series here on The Scuba Diving Channel. Just a reminder, it's even set up for those that aren't certified yet! So literally anyone can download this app (it's free). BONUS: There's a program to help you make more money by getting people to sign up! Become a “Buddy Pro” and start growing your following NOW:  Professional Divers, Operators, Facilities, Resorts, or Dive Shops: Get Buddy for Business – Download Buddy App for iOS Download Buddy App for Android https://www.tiktok.com/@divewithbuddy https://www.instagram.com/divewithbuddy/ — Kenny Dyal is the host of The Scuba Diving Podcast: TikTok: https://www.tiktok.com/@kenny_dyal Instagram: https://www.instagram.com/sweetwater_scuba Facebook: https://www.facebook.com/realkennydyal LinkedIn: www.linkedin.com/in/kennydyal Twitter: https://twitter.com/RealKennyDyal www.sweetwaterscuba.com

The Control Freak Podcast is a must-listen for those who are passionate about the art of Control in Magic: The Gathering. Hosted by LessAlex, a seasoned player and Control enthusiast, this podcast delves deep into the world of Control, discussing the latest strategies, trends, and developments in the format. In this episode, LessAlex is joined by special guest and Azorius Control extraordinaire George Jabbour, who brings his vast knowledge and expertise of Control to the table. Together, they explore the topic of the validity of Control in Modern, unpacking the nuances of the format and debunking common misconceptions. They also turn their attention to the state of Pioneer, analyzing the strengths and weaknesses of the format and sharing tips and insights for Control players looking to up their game. Inspiring, informative, and highly engaging, The Control Freak Podcast is a must-listen for anyone looking to master the art of Control in Magic: The Gathering. ---------------------------------------------------------------------------------- Follow George on Twitter here: https://twitter.com/jabjabber_   Help Support the Content here: https://www.patreon.com/LessAlex Join the Discord Here: https://discord.gg/VsfphMn Follow LessAlex on Twitter: https://twitter.com/LessAlex Like the LessAlex, The Control Freak Facebook Page here: https://www.facebook.com/profile.php?... Follow LessAlex on Twitch: https://www.twitch.tv/lessalex All my links: https://linktr.ee/LessAlex

Neste episódio vamos conversar com Elias Jabbour, professor de pós-graduação, mestre e doutor em Geografia Humana pela FFLCH-USP. Elias é autor de quatro livros e dezenas de artigos acadêmicos e de opinião sobre a China e o socialismo de mercado como uma nova formação econômico-social.

L'"Entre caixes" haur

Olga Llad

Want to successfully add life insurance products to your portfolio? Shane and Tonya talk with Jeff Havard, Regional Coordinator for National Farm Life Insurance, and Robby Jabbour, life and health insurance guru. From relationship building, leading with life insurance, golf games, and marketing, this episode will keep you laughing.Follow the IA Forward community of insurance agents on LinkedIn, Facebook, and Instagram, or learn more at iaforward.com

ELIAS JABBOUR é professor, GUILHERME CASARÕES é cientista político e CESAR CALEJON é jornalistas. Eles vão bater um papo sobre o futuro do Brasil. Já Vilela tem mais passado do que futuro.

On today's podcast I have two actors, ‘Lincoln Younis' and ‘Claude Jabbour' who are making a lot of noise in the 'Paramount +' series ‘Last King of The Cross.'  Both ‘Lincoln' and ‘Claude' play brothers in the latest telling of ‘John Ibraham's' story of Australia's most notorious nightclub mogul.  The series as debuted on ‘Paramount +' this week and you will be blown away by the intensity brought to the performances which we will talk about today on this episode.  We will discuss how the boys prepared for the role and if Lincoln was nervous to play the heightened role of ‘John Ibraham?' What their relationship with 'The Cross' has been like prior to filming? We will talk about the culture and importance of seeing first generation Australian's on screen Plus we will get plenty of exclusives from behind the scenes of 'Last King of The Cross.' Which I highly recommend watching this weekend.See omnystudio.com/listener for privacy information.

Hoje não tem meu e seu, é tudo NOSSO.

Whats up Kin! I'm back with an all new episode featuring my old friend Eddy Jabour who is now CastGRIT Life's new Co-Host!! We spend this episode catching up from the time I last recorded and what interested him in partnering up with me to bring you new and exciting CastGRIT content this 2023 and beyond! We share some great drams, drinking 7 year old Old Ezra straight bourbon, while laughing and telling great stories about how we see the world today and whats in our future. Great to be back on the mic with a great likeminded friend and looking forward to what we do in all our episodes to come. A must listen KIN!!

In the inaugural episode of The HemOnc Pulse, podcast host Chadi Nabhan, MD, MBA, FACP, talks with Hagop Kantarjian, MD, and Elias Jabbour, MD, both of the Department of Leukemia at the University of Texas MD Anderson Cancer Center. The trio cover high-impact studies, novel treatment strategies, and controversial standard-of-care approaches for AML as well as ALL that were presented at the 2022 American Society of Hematology Annual Meeting & Exposition.

Elias Jabbour é professor de economia da UERJ e autor.

Tune in to our newest episode of The Lebanese Physicians' Podcast with Dr. Pascal Jabbour discussing his pathway to a neurosurgical residency in the United States and his tips for success. We also discuss the research fellowships he is offering to help international medical graduates, specifically Lebanese graduates, succeed in neurosurgical research and in securing residency spots in the United States. We conclude discussing his wine making experience. We can't wait to taste his new product from Bordeaux in the next several years. #lebanon #neurosurgery #medicalresearch #wine You can also watch the episode on YouTube: https://youtu.be/yKkQol1LG6Q and listen to it on Apple, Spotify, iHeartRadio, and Anghami

Elias é professor da Faculdade de Ciências Econômicas da UERJ e manja muito de China.

ELIAS JABBOUR: O QUE MUDA NA CHINA DE XI? - 20 Minutos EntrevistaNo 20 MINUTOS desta segunda-feira (24/10) o professor de ciências econômicas da UERJ Elias Jabbour, autor do livro "China: O socialismo do século XXI", conversa com Breno Altman sobre as mudanças de Pequim na era de Xi Jinping. Assista ao vivo nos canais de Opera Mundi, a partir das 11h. Imperdível! Professor da Faculdade de Ciências Econômicas da UERJ e autor de "China: o socialismo do século XXI".----Quer contribuir com Opera Mundi via PIX? Nossa chave é apoie@operamundi.com.br (Razão Social: Última Instância Editorial Ltda.). Desde já agradecemos!Assinatura solidária: http://www.operamundi.com.br/apoio ★ Support this podcast ★

Elias Jabbour é geógrafo, professor universitário e escritor brasileiro. _________ ANFITRIÃO: Monark - Twitter @monark - Instagram @monarkoficial DIREÇÃO: Coca - Instagram @_coca1337 - Twitter @_coca1337 Canal de Cortes: https://rumble.com/c/CortesdoMonarkTalks https://www.youtube.com/c/MonarkTalksCortesOficial Grupo no Telegram: https://t.me/monarktalks Discord: https://discord.gg/8NKCaAuHf9

Ever wondered if those hours spent playing fantasy football can help with starting your agency? Shane and Tonya welcome Robby Jabbour as their guest to discuss stress factors, business questions, and choosing the right partner to start your agency.Interested in talking with Robby about owning an independent agency? Email him at robby@integraagent.com.

RENATA BARRETO é economista e ELIAS KHALIL JABBOUR é professor. Ela é especialista no mercado financeiro e ele é estudioso de tudo que envolve a China. O debate Capitalismo x Socialismo vai ser intenso, algo que o Vilela não presencia desde quando emprestou o estilingue pra David matar Golias.

Dr Jabbour discusses updates from the 2021 ASH Annual Meeting and Exposition in chronic myeloid leukemia, including findings from the phase 3 ASCEMBL trial (NCT03106779) evaluating asciminib (Scemblix) vs bosutinib (Bosulif) and data with ponatinib (Iclusig) from a post hoc analysis of the phase 2 OPTIC trial (NCT02467270).

ELIAS KHALIL JABBOUR é geógrafo, professor universitário e escritor. Elias é reconhecido por ser um dos maiores especialistas do Brasil nas questões do desenvolvimento econômico da China. O Vilela já foi pra China, quando ajudou a construir a muralha.

Caio Bellandi, Fagner Torres e Luara Ramos recebem Elias Jabbour, professor da UERJ e um dos autores do livro “China e o socialismo no século XXI". A forma de poder, o sistema econômico e o que pensa e pretende a nação que pode se tornar a mais influente e poderosa do planeta neste século.Pix: ladobdorio@yahoo.com

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Salma Jabbour, Clinical Chief of Radiation Oncology at Rutgers Cancer Institute. Together they discuss radiation oncology and its role in cancer care. For more information, please visit: www.CarisLifeSciences.com

Great episode with our new CastGRIT Kin Eddy, talking about how for generations his family has put their heart and soul into the people that work at and patronize their restaurants! It's another great story about the grit it takes to follow what your passionate about and make the sacrifices needed to succeed, regardless of the obstacles! If you like food, service and chasing your passions, you gotta hear this cast!